Physician profile
Suzanne Hall
NPI 1689674897
$4,643.52
in general payments reported to CMS, 2019-2025
37 companies · $656 in 2025
The $656 reported for 2025 was more than what 83% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $833 · 2020: $342 · 2021: $496 · 2022: $1,042 · 2023: $873 · 2024: $402 · 2025: $656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,846 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,845.81 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $642.38 | 2019-2024 | |
| Therapeuticsmd, INC. | $362.57 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $342.25 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $313.80 | 2021-2025 | |
| Medtronic, INC. | $285.40 | 2021-2022 | |
| Myovant Sciences INC. | $283.10 | 2021-2022 | |
| Astellas Pharma US INC | $278.11 | 2019-2025 | Veozah |
| Organon LLC | $221.64 | 2021-2025 | Nexplanon |
| Lupin INC. | $202.91 | 2019-2020 | |
| Amgen INC. | $182.15 | 2019-2025 | Evenity, Prolia, Prolia |
| Pfizer INC. | $169.03 | 2019-2025 | |
| Evofem Biosciences, INC. | $133.47 | 2021-2022 | |
| Coopersurgical, INC. | $121.67 | 2019-2024 | Paragard T 380a |
| Daiichi Sankyo INC. | $120.99 | 2020-2025 | Injectafer |
| Hologic Sales and Service, LLC | $109.00 | 2021-2024 | Coolseal Generator, Aptima |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $101.15 | 2019-2020 | |
| Covidien LP | $83.04 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $69.16 | 2020-2023 | |
| Millicent US INC | $68.57 | 2024-2025 | Femring, Intrarosa |
| Shield Therapeutics INC | $65.19 | 2022-2025 | Accrufer |
| Merck Sharp & Dohme LLC | $57.38 | 2020-2023 | Gardasil 9 |
| Channel Medsystems, INC. | $53.48 | 2025 | |
| Caldera Medical, INC | $49.39 | 2023 | Desara |
| Mylan Pharmaceuticals INC. | $46.45 | 2019-2022 | |
| Smith+Nephew, INC. | $34.25 | 2022-2025 | Stravix |
| Agile Therapeutics, INC. | $31.66 | 2022 | |
| Duchesnay USA Incorporated | $24.99 | 2019 | |
| Avion Pharmaceuticals | $24.80 | 2021 | |
| Baxter Healthcare | $21.52 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Dexcom, INC. | $21.42 | 2025 | Dexcom G6 Transmitter |
| Ethicon US, LLC | $20.08 | 2022 | |
| Exact Sciences Corporation | $19.38 | 2024 | Cologuard Collection Kit |
| Biogen, INC. | $19.35 | 2025 | Zurzuvae |
| Convatec INC. | $17.32 | 2022 | |
| Exeltis, USA INC. | $16.52 | 2025 | Slynd |
| Axonics, INC. | $15.04 | 2022 | |
| Octapharma USA, INC. | $14.91 | 2025 | Fibryga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.